pharmacie et médicaments – Remise en cause du plafond des remises génériques

This written question concerns the pricing and reimbursement of medicines in France, specifically focusing on the rebate system for generic drugs. It questions whether the current rebate cap is appropriate and if it impacts the availability or affordability of essential medications. The question is posed by a French Member of Parliament to the government, highlighting potential impacts on the pharmaceutical sector, healthcare providers, and ultimately, patients who rely on these medicines.